Vivimed Labs (NSE:VIVIMEDLAB) Total Tax Payable: ₹0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VIVIMEDLAB Vivimed Labs Ltd NSE:VIVIMEDLAB
43 GF Score
Price ₹5.22
GF Value ₹2.54
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Vivimed Labs Total Tax Payable?

Vivimed Labs NSE:VIVIMEDLAB -0.57% 43 Total Tax Payable is ₹0.0 Mil as of Dec. 2025. GuruFocus rates NSE:VIVIMEDLAB with a GF Score™ of 43/100 and a GF Value™ of ₹2.54 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Vivimed Labs's Total Tax Payable for the quarter that ended in Dec. 2025 was ₹0.0 Mil.

Vivimed Labs's quarterly Total Tax Payable increased from Jun. 2025 (₹0.0 Mil) to Sep. 2025 (₹180.0 Mil) but then declined from Sep. 2025 (₹180.0 Mil) to Dec. 2025 (₹0.0 Mil).

Vivimed Labs Total Tax Payable Related Terms

Vivimed Labs Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Vivimed Labs's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivimed Labs Total Tax Payable Chart

Vivimed Labs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 185.68 0.00 0.00 0.00

Vivimed Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 180.03 0.00
NSE:VIVIMEDLAB
43GF Score
Vivimed Labs Ltd NSE:VIVIMEDLAB
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivimed Labs Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of ₹0.0 Mil mean?
Vivimed Labs (NSE:VIVIMEDLAB) has a Total Tax Payable of ₹0.0 Mil as of Dec. 2025. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Vivimed Labs and its competitors.
Is Vivimed Labs' Total Tax Payable too high?
Vivimed Labs' current Total Tax Payable is ₹0.0 Mil. Overall, Vivimed Labs has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vivimed Labs' Total Tax Payable compare to ZTS and UTHR?
Vivimed Labs' Total Tax Payable of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Vivimed Labs and its competitors. Vivimed Labs's current Total Tax Payable is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivimed Labs stock overvalued right now?
Based on GuruFocus' analysis, Vivimed Labs (NSE:VIVIMEDLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹2.54, compared to a current price of ₹5.22 — trading 105.5% above its estimated fair value. The current Total Tax Payable is ₹0.0 Mil. Vivimed Labs' overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Vivimed Labs (NSE:VIVIMEDLAB), the current Total Tax Payable is ₹0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivimed Labs (NSE:VIVIMEDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vivimed Labs stock appears to be overvalued. The current stock price of ₹5.22 is trading 105.5% above its estimated GF Value™ of ₹2.54. GuruFocus considers Vivimed Labs to be Significantly Overvalued.

Key valuation signals for NSE:VIVIMEDLAB:

  • Total Tax Payable: ₹0.0 Mil
  • GF Value™: ₹2.54 vs. price of ₹5.22 (105.5% above fair value)
  • GF Score™: 43/100 with 7 warning signs

No single metric tells the full story. See the NSE:VIVIMEDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vivimed Labs Business Description

Other Exchanges 532660:India
Address Green Lands, Beside The Plaza Hotel, D.No. 6-3-866/1/G1, 3rd & 4th Floor, GMR Towers, Begumpet, Hyderabad, TG, IND, 500016
Vivimed Labs Ltd is an India-based company that is engaged in the Business of Active pharmaceutical ingredients, Intermediates, Nutraceutical ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals, and Retail Branded Formulation manufacturing. The company has three reportable segments: the Speciality Chemicals Business, the Pharma Business, and others. The majority of revenue is earned through the Pharma business.
43GF Score

Get the complete analysis for NSE:VIVIMEDLAB

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.22
Price
₹2.54
GF Value